Mississippi Medical Cannabis Program


This page has been automatically translated from English. MSDH has not reviewed this translation and is not responsible for any inaccuracies.

The Mississippi State Department of Health is committed to meeting the statutory requirements of the Mississippi Medical Cannabis Act. Our goal is to provide a safe and accessible program that meets the needs of patients and the public health and safety of all Mississippi residents.

MSDH is currently working to establish licensing and patient registry systems in accordance with the Mississippi Medical Cannabis Act (Senate Bill 2095)

E-mail updates about the Mississippi Medical Cannabis Program and its regulations are free.


Beginning at 8:00 a.m. on Wednesday, June 1, 2022, applications and licenses will be accepted online for individuals and businesses.

Applications and licenses will be accepted online for:

  • patients
  • medical practitioners
  • cannabis cultivation facilities
  • cannabis processing facilities
  • cannabis testing facilities
  • cannabis waste disposal entities
  • cannabis transportation entities

Approval times: Once the application process begins, there will be a 30-day approval time for licensure applications, and a five-day approval time for program patients.

Dispensaries: The Mississippi Department of Revenue will be responsible for the licensing of medical cannabis dispensaries.

Pre-Application Checklist

If you are a patient with plans to register for medical cannabis use, or an individual or entity intending to apply for a license as a practitioner, caregiver, patient or business (cultivation, disposal, processing, research, testing, transportation), please review the general guide below to be better prepared.

Proposed Regulations

MSDH is developing regulations for all aspects of medical cannabis production. Some initial proposed regulations are below.

Current Regulations

Documents and Forms

Business Registration

If a company plans to apply for licensure through the Mississippi State Department of Health for any aspect of the Mississippi Medical Cannabis Program, potential applicants should first register with the Mississippi Secretary of State's Office.

As part of this registration, entities are required to select an NAICS Code as part of their formation or registration. If the company is interested in being licensed to participate in the Medical Cannabis Program, the applicable NAICS codes are given below.

Type of LicensureNAICS Code
Transporter (local freight)484220
Transporter (long distance)484230
Testing Facility621511
Waste Disposal562211

Cultivation and Availability

The Mississippi Medical Cannabis Act requires that cultivation of marijuana occur indoors in secure facilities, and that these facilities must be located in Mississippi if they provide products available to those with patient identification cards.

In order to ensure that individuals participating in the program receive products that have been tested and fall within the limits set by the Mississippi Legislature, MSDH anticipates that products will become available to patients in late 2022 to allow for cultivation of marijuana in the state and safety testing.

Qualifying Conditions

The following medical conditions or their treatment qualify for participation in the Mississippi Medical Cannabis Program:

  • cancer
  • Parkinson's disease
  • Huntington's disease
  • muscular dystrophy
  • glaucoma
  • spastic quadriplegia
  • positive status for human immunodeficiency virus (HIV)
  • acquired immune deficiency syndrome (AIDS)
  • hepatitis
  • amyotrophic lateral sclerosis (ALS)
  • Crohn's disease
  • ulcerative colitis
  • sickle-cell anemia
  • Alzheimer's disease
  • agitation of dementia
  • post-traumatic stress disorder (PTSD)
  • autism
  • pain refractory to appropriate opioid management
  • diabetic/peripheral neuropathy
  • spinal cord disease or severe injury

Also qualifying is a chronic terminal or debilitating disease or medical condition or its treatment that produces one or more of the following:

  • cachexia or wasting syndrome
  • chronic pain
  • severe or intractable nausea
  • seizures
  • severe and persistent muscle spasms including, but not limited to, those characteristic of multiple sclerosis

For inquiries about the Mississippi Medical Cannabis Program, send e-mail to MSMedicalCannabis@msdh.ms.gov

Last reviewed on Nov 6, 2020

Related resources

More topics

Sign up for weekly public health updates by e-mail: 
Mississippi State Department of Health 570 East Woodrow Wilson Dr Jackson, MS 39216 866-HLTHY4U Contact and information

Facebook Twitter Instagram RSS

Accredited by the national Public Health Accreditation Board